|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Cyteir Therapeutics (NASDAQ: CYT) through any online brokerage.
There are no as such competitors for Cyteir Therapeutics.
The latest price target for Cyteir Therapeutics (NASDAQ: CYT) was reported by Wedbush on July 13, 2021. The analyst firm set a price target for 40.00 expecting CYT to rise to within 12 months (a possible 125.86% upside). 4 analyst firms have reported ratings in the last year.
The stock price for Cyteir Therapeutics (NASDAQ: CYT) is $17.71 last updated Today at 6:46:57 PM.
There are no upcoming dividends for Cyteir Therapeutics. The last dividend paid out to investors was $0.01 on November 6, 2015.
There is no upcoming split for Cyteir Therapeutics.
Cyteir Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.